UI Hospitals and Clinics

News Article

UI Pharmacy Residency Celebrates 50 Years of ASHP Accreditation

In 1949, University of Iowa Hospitals and Clinics began training post-graduate pharmacists in residency training. The UI Department of Pharmaceutical Care leadership were pioneers in creating pharmacy residency programs and contributed to the rigorous American Society of Health-System Pharmacists (ASHP) Standards for Accreditation. In 1963, our PGY1 Pharmacy Practice Residency program was the first ASHP-accredited pharmacy residency training program in the U.S. Currently, the number of ASHP-accredited pharmacy residency programs in the U.S. has grown to 1,616, comprising a total of 3,386 residency positions.

Since our first accreditation, the UI Department of Pharmaceutical Care has partnered with the University of Iowa College of Pharmacy to add the following post-doctoral residency training programs:

  • PGY1 in Community Pharmacy Practice
  • PGY2 Specialty Residency in Pediatrics
  • PGY1/2 in Health-System Pharmacy Administration (with MPH degree)
  • PGY2 Specialty Residency in Critical Care
  • PGY2 Specialty Residency in Ambulatory Care

Our programs participate in the National Matching Services© and, this year, we have 19 resident pharmacists. Since 1949, the UI Department of Pharmaceutical Care has trained 482 resident pharmacists.

Pharmacy residencies are post-graduate training programs that provide advanced clinical, academic, research, operational, and administrative training for advancing health care and patient outcomes related to medication therapy. In addition to an intense hands-on experience, resident learning is enhanced by a formalized curriculum that promotes continuous learning and critical thinking. Our residency programs provide tremendous value to University of Iowa Health Care and the profession of pharmacy through improved recruitment and retention, enhanced employee engagement, implementation of quality and safety initiatives, implementation of system-based process improvements, cost-savings and revenue enhancement, clinical research development, and educational development.

Read the Iowa Now article.